Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Exactly as you said!


Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled (10 sites in US; 5 currently open to enrollment)
• 60 subjects – 30 each of drug or placebo (Water for Injection)
• “Swish and spit” brilacidin 3x/daily for 7 weeks – 16 ml oral rinse
• Interim analysis after 36 subjects (18 per treatment group) by a Data Monitoring Committee (DMC); will review safety
and efficacy results